stockportfolio.pro
Stocks / PRCT vs PRGO
PRCT vs PRGO
PROCEPT BioRobotics Corporation and Perrigo Company plc side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| PROCEPT BioRobotics Corporation (PRCT) | Perrigo Company plc (PRGO) | |
|---|---|---|
| Market cap | $1.5B | $1.6B |
| Revenue (latest FY) | $308.05M | $4.25B |
| Net income (latest FY) | $-95.57M | $-1.43B |
| Revenue growth (5y CAGR) | 109.0% | 0.8% |
| Net margin | -31.0% | -33.5% |
| Return on equity | -26.1% | -48.6% |
| P/E ratio | — | — |
| Dividend yield | — | 10.4% |
| Profitable years (of last 10) | 0 | 3 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open PRCT — free Open PRGO — freeFrequently asked questions
Which is bigger, PRCT or PRGO?
Perrigo Company plc is larger by market capitalization — $1.6B versus $1.5B.
Which grows faster, PRCT or PRGO?
Over the last five fiscal years, PROCEPT BioRobotics Corporation grew revenue faster — 109.0%/yr versus 0.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.